ArticleCancer immunology, immunotherapy : CII2025
Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemia.
Weiwang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it